Pamela Stephenson is CCO at ALBIREO PHARMA, INC. (ALBO). They have made 5 open-market trades across 3 companies since 2020, most recently 2026-02-17.
CIK 0001767650
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IRON | 80,998 | $4.6M |
| ALBO | 97,755 | $4.3M |
| ZYNE | 75,893 | $99K |
| Total | $9.0M |
Shares reported on the most recent Form 4, priced at the 2026-02-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IRON | SELL | 2026-02-17 | 2026-02-17 | $62.86 | $348K | +4.5% | -7.2% | +4.9% |
| IRON | SELL | 2025-02-18 | 2025-02-20 | $54.58 | $342K | +0.5% | -2.5% | -11.3% |
| ZYNE | SELL | 2023-06-14 | 2023-06-15 | $0.35 | $40 | -5.8% | +0.0% | +280.0% |
| ALBO | SELL · 10b5-1 | 2023-01-23 | 2023-01-23 | $43.80 | $4K | +1.8% | -0.6% | N/A |
| ALBO | SELL | 2023-01-19 | 2023-01-20 | $43.90 | $156K | +2.0% | -0.1% | N/A |
| ALBO | SELL · 10b5-1 | 2022-12-27 | 2022-12-27 | $19.06 | $9K | +143.6% | +144.2% | N/A |
| ALBO | SELL · 10b5-1 | 2022-10-24 | 2022-10-25 | $19.58 | $2K | +8.2% | +10.4% | +119.7% |
| ALBO | SELL · 10b5-1 | 2022-09-26 | 2022-09-27 | $19.40 | $9K | +3.1% | -1.3% | -9.8% |
| ALBO | SELL · 10b5-1 | 2022-07-22 | 2022-07-25 | $24.67 | $3K | +2.1% | -18.4% | -14.7% |
| ALBO | SELL · 10b5-1 | 2022-06-27 | 2022-06-28 | $19.47 | $9K | +25.5% | +20.1% | -1.9% |
| ZYNE | SELL | 2022-06-14 | 2022-06-16 | $1.01 | $40 | +8.5% | +3.8% | +8.5% |
| ALBO | SELL · 10b5-1 | 2022-04-22 | 2022-04-25 | $32.92 | $3K | -7.1% | -39.7% | -30.2% |
| ALBO | SELL · 10b5-1 | 2022-03-28 | 2022-03-29 | $30.53 | $14K | +14.5% | +1.3% | -38.9% |
| ALBO | SELL · 10b5-1 | 2022-01-24 | 2022-01-25 | $24.88 | $10K | +18.3% | +28.5% | +29.9% |
| ALBO | SELL · 10b5-1 | 2021-12-27 | 2021-12-27 | $23.92 | $11K | +8.6% | +11.9% | +29.1% |
| ALBO | SELL · 10b5-1 | 2021-09-27 | 2021-09-28 | $32.05 | $14K | -3.9% | -7.7% | -24.1% |
| ALBO | SELL · 10b5-1 | 2021-06-25 | 2021-06-28 | $36.01 | $17K | -0.3% | -17.3% | -10.1% |
| ALBO | SELL · 10b5-1 | 2021-03-29 | 2021-03-31 | $34.02 | $14K | -8.4% | -9.7% | +0.6% |
| ALBO | SELL · 10b5-1 | 2020-12-28 | 2020-12-29 | $39.07 | $18K | -0.3% | -0.5% | -8.4% |
| ALBO | SELL · 10b5-1 | 2020-09-25 | 2020-09-25 | $33.20 | $15K | +9.6% | -1.7% | +15.9% |
| ALBO | SELL · 10b5-1 | 2020-06-25 | 2020-06-26 | $30.79 | $12K | -15.2% | -15.0% | +9.0% |
| ALBO | SELL · 10b5-1 | 2020-03-25 | 2020-03-25 | $17.60 | $31K | -11.5% | +10.4% | +52.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.